Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0000899243-19-017407

Options or other derivatives

  • Chief Medical Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tasker Sybil Chief Medical Officer 2019-06-17 Grant or award · Stock Options (option to buy) +20,000 20,000 D
Loading xslF345X03/doc4.xml…